Effect of add‐on administration of kamikihito with donepezil monotherapy in a patient with Alzheimer's disease
Kazuyuki Ishida
Abstract
Kazuyuki Ishida
Abstract
ABSTRACT Case A 69‐year‐old male presented with a two‐year history of memory decline. Results of his cognitive function tests suggested cognitive impairment and brain magnetic resonance imaging showed cortical atrophy, predominantly in the temporal lobes. Based on these findings, he was diagnosed with Alzheimer's disease. Outcome Although treatment with donepezil was commenced, the patient's cognitive function deteriorated in the year after initiation. However, his cognitive impairment improved in the year after add‐on administration of kamikihito, a traditional Japanese herbal medicine, with donepezil monotherapy. Conclusion Combination therapy with donepezil and kamikihito seems to be beneficial and worth considering for patients who are secondarily non‐responsive to donepezil monotherapy.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
ABSTRACT Case A 69‐year‐old male presented with a two‐year history of memory decline. Results of his cognitive function tests suggested cognitive impairment and brain magnetic resonance imaging showed cortical atrophy, predominantly in the temporal lobes. Based on these findings, he was diagnosed with Alzheimer's disease. Outcome Although treatment with donepezil was commenced, the patient's cognitive function deteriorated in the year after initiation. However, his cognitive impairment improved in the year after add‐on administration of kamikihito, a traditional Japanese herbal medicine, with donepezil monotherapy. Conclusion Combination therapy with donepezil and kamikihito seems to be beneficial and worth considering for patients who are secondarily non‐responsive to donepezil monotherapy.
Key concepts: Donepezil, Cognition, Medicine, Magnetic resonance imaging, Cognitive impairment, Disease, Atrophy, Alzheimer's disease